Search results

Improved Reimbursement for Endoscopic Cyclophotocoagulation (ECP) when Combined with Cataract Surgery

CMS addresses feedback from the medical community by elevating CPT reimbursement for new combined cataract and ECP codes[1]Reimbursement increase effective January 1, 2020 is $931 and $1,900 for ASCs and hospitals, respectively[2] ECP is a safe and effective surgical procedure to reduce intraocular pressure[3] in patients suffering from glaucoma Waltham, MA – January 00 2020...

TPG Capital backs BVI to Acquire PhysIOL Group SA

Combination to create a comprehensive cataract product portfolio and expand footprint into new and existing markets. Transaction marks third addition to the BVI platform, following company’s acquisitions of Malosa Medical and Vitreq. Waltham, Mass – December 20, 2018 – BVI (Beaver-Visitec International), a leading developer, manufacturer, and marketer of specialized...

PhysIOL® to Launch FineVision Triumf®– the First and Only Trifocal EDOF IOL – Raising the Bar for Presbyopia-Correction

The next generation FineVision Triumf Intraocular Lens (IOL) extends the market-leading FineVision® Trifocal family and builds on 9 years of clinical experience since PhysIOL launched the world’s first Trifocal IOL The FineVision Triumf IOL, for use in Europe currently, effectively restores visual function at distances from far to near. The visual acuity for the intermediate...

BVI Expands Vitreoretinal Surgery Presence

Acquisition of Arcadophtha increases BVI’s market position by adding a specialist in vitreoretinal surgical liquids and gases Waltham, MA – December 6, 2019 – BVI, one of the fastest growing diversified companies in ophthalmology, today announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used...

BVI Medical names Shervin Korangy as President and Chief Executive Officer

Waltham, Mass – May 16, 2019 – BVI Medical, Inc. (BVI), a leading developer, manufacturer, and marketer of surgical devices for the ophthalmic marketplace, announced today that it has named Shervin Korangy as President and Chief Executive Officer. He has also been appointed to BVI’s Board of Directors. Most recently, Korangy served as Chief...

Optimizing Efficiency in Intravitreal Injections

Malosa Medical Announces the Release of the Intravitreal Injection Guide We are proud to announce the release of our Intravitreal Injection Guide (MMSU1577) – designed to facilitate IVT injections while reducing patient discomfort and anxiety. MMSU1577 Malosa Intravitreal Injection Guide (IVT) Video Designed by UK-based ophthalmologist, Mr. Salman Waqar, MBBS, FRCOphth, the...

Search Results